Diffuse Large B Cell Lymphoma

Showing 26 - 50 of 206

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Large B-cell Lymphoma, Diffuse Large B Cell Lymphoma Trial in Homburg (R-miniCHOP + Acalabrutinib, R-miniCHOP)

Not yet recruiting
  • Large B-cell Lymphoma
  • Diffuse Large B Cell Lymphoma
  • Homburg, Saarland, Germany
    Saarland University Medical Center
Apr 19, 2023

Diffuse Large B Cell Lymphoma Trial in Suzhou (Rituximab, Orelabrutinib, Pomalidomide)

Recruiting
  • Diffuse Large B Cell Lymphoma
  • Suzhou, Jiangsu, China
    the First Affiliated Hospital of Soochow University
Apr 10, 2023

Diffuse Large B Cell Lymphoma Trial in Tampa (Itacitinib, Chimeric antigen receptor (CAR) T-cell therapy)

Recruiting
  • Diffuse Large B Cell Lymphoma
  • Itacitinib
  • Chimeric antigen receptor (CAR) T-cell therapy
  • Tampa, Florida
    Moffitt Cancer Center
Mar 6, 2023

Advanced Cancer, Follicular Lymphoma, Peripheral T Cell Lymphoma Trial (BR1733)

Not yet recruiting
  • Advanced Cancer
  • +3 more
  • (no location specified)
Feb 27, 2023

Including miRNA-based Tumor Signatures in Diffuse Large B Cell

Not yet recruiting
  • Diffuse Large B Cell Lymphoma
  • Relapsed Non-Hodgkin Lymphoma
  • no intervention (observational study)
  • Napoli, Italy
  • +2 more
Feb 17, 2023

Diffuse Large B-Cell Lymphoma Patients Treated With CAR-T Cell

Not yet recruiting
  • Diffuse Large B Cell Lymphoma
  • Gut microbiome analysis
  • Bologna, Italy
    Institute Of Hematology "Seràgnoli"
Feb 10, 2023

Chronic Lymphocytic Leukemia, Mantle Cell Lymphoma, Acute Lymphoblastic Leukemia Trial in Tampa (Fludarabine, Cyclophosphamide,

Recruiting
  • Chronic Lymphocytic Leukemia
  • +4 more
  • Tampa, Florida
    Moffitt Cancer Center
Jan 12, 2023

Diffuse Large B Cell Lymphoma Trial (Epcoritamab, Lenalidomide)

Not yet recruiting
  • Diffuse Large B Cell Lymphoma
  • (no location specified)
Jan 20, 2023

Diffuse Large B Cell Lymphoma Trial in Worldwide (Tafasitamab, Lenalidomide)

Recruiting
  • Diffuse Large B Cell Lymphoma
  • Dallas, Texas
  • +29 more
Jan 20, 2023

Lymphoma, Non-Hodgkin, Diffuse Large B Cell Lymphoma, Follicular Lymphoma Trial in New York (Venetoclax, Tazemetostat)

Not yet recruiting
  • Lymphoma, Non-Hodgkin
  • +2 more
  • New York, New York
    Weill Cornell Medicine/NewYork-Presberteryian Hospital
Jan 18, 2023

Axicabtagene Ciloleucel:Neurocognitive and Patient-Reported

Active, not recruiting
  • Diffuse Large B Cell Lymphoma
  • Transformed Lymphoma
  • Handgrip strength test
  • +9 more
  • Tampa, Florida
    Moffitt Cancer Center
Jan 12, 2023

CLL/SLL, NHL, Mantle Cell Lymphoma Trial in United States (SYNCAR-001, STK-009, Cyclophosphamide)

Recruiting
  • CLL/SLL
  • +6 more
  • Duarte, California
  • +4 more
Jan 12, 2023

Non Small Cell Lung Cancer, Head and Neck Squamous Cell Carcinoma, Triple Negative Breast Cancer Trial in United States

Recruiting
  • Non Small Cell Lung Cancer
  • +11 more
  • Denver, Colorado
  • +3 more
Jan 10, 2023

Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, Follicular Lymphoma Trial in Australia, China (BGB-10188,

Recruiting
  • Chronic Lymphocytic Leukemia
  • +9 more
  • Adelaide, Australia
  • +12 more
Jan 6, 2023

Diffuse Large B Cell Lymphoma Trial in Rouen (CAR-T cells monitoring)

Not yet recruiting
  • Diffuse Large B Cell Lymphoma
  • CAR-T cells monitoring
  • Rouen, France
    Centre Henri Becquerel
Dec 22, 2022

Diffuse Large B Cell Lymphoma Trial (anti-CD19 CAR NK cells)

Not yet recruiting
  • Diffuse Large B Cell Lymphoma
  • anti-CD19 CAR NK cells
  • (no location specified)
Dec 21, 2022

Diffuse Large B Cell Lymphoma Trial in Philadelphia (Nivolumab, IV, 240 mg)

Active, not recruiting
  • Diffuse Large B Cell Lymphoma
  • Nivolumab, IV, 240 mg
  • Philadelphia, Pennsylvania
    Fox Chase Cancer Center
Jan 3, 2023

B Cell Lymphoma, Aggressive Lymphoma, Diffuse Large B Cell Lymphoma Trial in Saint Louis (Mosunetuzumab)

Recruiting
  • B Cell Lymphoma
  • +5 more
  • Saint Louis, Missouri
    Washington University School of Medicine
Jan 3, 2023

Waldenstrom Macroglobulinemia, Multiple Myeloma, Chronic Lymphocytic Leukemia Trial in Worldwide (Iopofosine I 131 single dose,

Recruiting
  • Waldenstrom Macroglobulinemia
  • +8 more
  • Iopofosine I 131 single dose
  • +2 more
  • Redlands, California
  • +42 more
Dec 30, 2022

Diffuse Large B Cell Lymphoma, DLBCL, Cancer Trial in Madison (Rituximab, Cyclophosphamide, Doxorubicin)

Recruiting
  • Diffuse Large B Cell Lymphoma
  • +2 more
  • Madison, Wisconsin
    University of Wisconsin Carbone Cancer Center
Dec 12, 2022

B-cell Non-Hodgkin Lymphoma, Diffuse Large B Cell Lymphoma, Follicular Lymphoma Trial (IKS03)

Not yet recruiting
  • B-cell Non-Hodgkin Lymphoma
  • +4 more
  • (no location specified)
Dec 7, 2022

Patients Previously Treated WithMustang Bio CAR-T Cell

Enrolling by invitation
  • Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)
  • +10 more
  • Prior MB-102 CAR-T cell investigational product.
  • Prior MB-106 CAR-T cell investigational product.
  • Duarte, California
  • +4 more
Dec 8, 2022